SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-23-000005
Filing Date
2023-01-12
Accepted
2023-01-12 14:22:32
Documents
15
Period of Report
2023-01-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K evfm-20230112.htm   iXBRL 8-K 34017
2 EX-99.1 ex99120230112_evfmheyfavor.htm EX-99.1 12296
7 image_0.jpg GRAPHIC 27428
  Complete submission text file 0001618835-23-000005.txt   251143

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20230112.xsd EX-101.SCH 2292
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20230112_def.xml EX-101.DEF 14483
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20230112_lab.xml EX-101.LAB 27846
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20230112_pre.xml EX-101.PRE 14979
9 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20230112_htm.xml XML 10798
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 23525694
SIC: 2834 Pharmaceutical Preparations